Literature DB >> 14745164

Isolation of tryptophan as an inhibitor of ovalbumin permeation and analysis of its suppressive effect on oral sensitization.

Jun Watanabe1, Kyoko Fukumoto, Eri Fukushi, Kei Sonoyama, Jun Kawabata.   

Abstract

Tryptophan was isolated from rat feces as an active compound against ovalbumin permeation in an in vitro Caco-2 cell model. Tryptophan dose-dependently inhibited ovalbumin permeation with accompanying increase in transepithelial electric resistance, and its inhibitory activity reached a plateau at 10 mM. Brown Norway rats were sensitized by intragastric administration of ovalbumin together with or without tryptophan. Antibody levels specific to ovalbumin in the sera and proliferative responses of spleen mononuclear cells to ovalbumin were significantly lower in rats administered ovalbumin plus tryptophan than those administered ovalbumin alone. These results suggest that tryptophan suppresses oral sensitization to ovalbumin, probably via suppression of ovalbumin absorption from the intestinal tract.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745164     DOI: 10.1271/bbb.68.59

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  5 in total

Review 1.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

Review 2.  Nutritional Keys for Intestinal Barrier Modulation.

Authors:  Stefania De Santis; Elisabetta Cavalcanti; Mauro Mastronardi; Emilio Jirillo; Marcello Chieppa
Journal:  Front Immunol       Date:  2015-12-07       Impact factor: 7.561

3.  Cane molasses as a source of precursors in the bioproduction of tryptophan by Bacillus subtilis.

Authors:  Marzieh Dehghan Shasaltaneh; Zahra Moosavi-Nejad; Sara Gharavi; Jamshid Fooladi
Journal:  Iran J Microbiol       Date:  2013-09

4.  Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.

Authors:  Marcin Krawczyk; Dominika Maciejewska; Karina Ryterska; Maja Czerwińka-Rogowska; Dominika Jamioł-Milc; Karolina Skonieczna-Żydecka; Piotr Milkiewicz; Joanna Raszeja-Wyszomirska; Ewa Stachowska
Journal:  Nutrients       Date:  2018-11-18       Impact factor: 5.717

Review 5.  Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?

Authors:  Rima M Chakaroun; Lucas Massier; Peter Kovacs
Journal:  Nutrients       Date:  2020-04-14       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.